Siemens Healthcare and the Cardio-Thoracic Center of Monaco (CCM) signed a partnership contract in Monaco. Within the framework of this contract, CCM was nominated the first “Siemens European Reference Center Cardiovascular Medicine". The strategic partnership is dedicated to the entire spectrum of cardiovascular medicine with the objective to develop innovative solutions for the treatment…
In the light of global climate change, the relations between weather and health are of increasing interest. A drop in the average temperature outside is linked to a higher risk of people having heart attacks, according to a new study published on bmj.com today. UK researchers found that each 1°C reduction in temperature on a single day is associated with around 200 extra heart attacks.
Does diabetes further increase the risk of death in patients diagnosed with cancer? A team at the Johns Hopkins School of Medicine in Baltimore, Maryland, has discovered something very sobering: Cancer patients are 51% to 85% more likely to die after surgical resection if they had pre-existing diabetes.
Initiated in 1999, the Heinz Nixdorf Recall Study involved 4,814 European participants. The results proved, for the first time, the connection between coronary calcifications and the risk of heart attack, according to scientists at the University Hospital in Essen. The finding by no means exhausted the potential inherent in the surveys. Subsidised until 2013, researchers are examining coronary…
Surgeon Alain Carpentier is ready to remove a patient’s heart and replace it with a mechanical device he spent 15 years developing. By 2013 the procedure will be performed on 50 European patients as part of a clinical trial to win CE approval for the world’s first fully implantable artificial heart.
After years of go-slow adoption and cautious optimism, European cardiologists are now embracing remote monitoring of cardiac electrophysiology devices. ‘We are at the dawn of a new era,’ concluded Dr Philippe Ritter, Chairman of the Cardiostim 2010 congress, after reviewing findings of studies that delivered unequivocal evidence that remote monitoring is not only a safe alternative to clinic…
Drug-eluting stents to treat narrowed coronary vessels met with sensational success, and then things became rather quiet. Now, two new developments from Cordis and Biotronik are being tested at Essen University Hospital, Germany. We asked Professor Holger Eggebrecht, head of the hospital’s cardiac catheter lab, why these new models look important.
Ongoing technical developments in computed tomography (CT) such as dual source CT have established coronary CT angiography (cCTA) as a robust non-invasive imaging test for the assessment of coronary artery disease. The most important advantage of cCTA over conventional catheter-based coronary angiography is that not only the coronary lumen but also the entire coronary artery wall is visualized…
The focus on Coronary artery disease – from genes to outcomes at ESC 2010 underlines the importance of CAD diagnosis on the scientific agenda. During the session ‘Multi modality imaging to detect coronary artery disease’, chaired by Professor JJ Bax, of the Cardiology Department at Leiden University Medical Centre, the Netherlands, experts will discuss, for example, the advantages of the…
When in 1992 Dr Luigi Marzio Biasucci, head of the Sub-intensive Care Unit at the Catholic University of the Sacred Heart in Rome, Italy, published with his team the first paper on C-reactive protein (CRP) in unstable angina, few people believed in the diagnostic power of biochemical features to measure the effects or progress of disease, illness, or a condition. Today, biomarker tests are part…
Patients with heart failure with normal ejection fraction (HFNEF) also referred to as ‘stiff heart’, show a normal ejection fraction and severe diastolic dysfunction. President of the Austrian Society of Cardiology, Professor Irene Lang warns: ‘It is particularly concerning that stiff heart is a little known and insufficiently researched cardiac condition -- a stepchild in research,…
Five days at ESC 2010, the world’s biggest international cardiology meeting -- with the Spotlight 2010 strongly focused on "Coronary Artery Disease: From Genes To Outcomes", but yes, so much more, too. This year’s programme is based on 4167 abstracts selected from more than 9,500 submissions, as well as over 120 Hotline and Clinical Trial Update presentations. From these, 35 Hotline sessions…
A team led by UK-based researchers has found that having diabetes doubles the risk of developing a wide range of blood vessel diseases, including heart attacks and different types of stroke. The consortium, headed by Dr Nadeem Sarwar and Professor John Danesh of the University of Cambridge, analysed data from the individual records on 700,000 people, each of whom was monitored for about a decade…
The daily management of diabetes mellitus is a complex interaction between blood glucose measuring, lifestyle aspects and drug therapy. Large epidemiological trials such as UKPDS (United Kingdom Diabetes Prospective Study) have shown that an optimal blood glucose adjustment has beneficial long-term effects on type-2 diabetics’ risk of micro- and macrovascular secondary complications.
The landmark achievements in interventional cardiology that are rapidly advancing minimally invasive surgeries (MIS) on a beating heart were demonstrated during a Paris course on revascularisation (EuroPCR), the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Renewing Health is the Veneto Region’s response to the third Call of Proposals by the European Information Communication Technology Policy Support Programme (ICT-PSP). The project, which falls under the ICT-PSP financing plans, aims to facilitate the use of ICT-based solutions and services for citizens, the government, and businesses, as well as aiding their diffusion throughout Europe.
The teaching hospital in Olomouc aims to become a national centre for telemedicine. A telemedicine system is currently used by the hospital’s Internal Medicine Department 1 for cardiac patients and almost a hundred patients are remotely monitored via a telesystem implemented by the hospital.
If patients suffering acute myocardial infarction, heart failure, or pneumonia are admitted to hospitals that frequently treat these illnesses they are less likely to die, according to research published in the New England Journal of Medicine.
At 12 months the NEVO Sirolimus-eluting Coronary Stent has continued to demonstrate excellent safety and efficacy outcomes compared to Taxus Liberte according to new data presented today from the NEVO RES-I clinical trial. These results were presented as a late breaking trial at EuroPCR, the leading medical conference in Europe for physicians specializing in interventional cardiovascular…
Although cardiac computed tomography (cCT) has shown very good diagnostic accuracy for the detection of coronary artery disease, the physiologic significance of many lesions can be uncertain. Furthermore, the presence of calcified atherosclerotic plaque reduces the ability to differentiate significant stenosis from non obstructive plaque.
Hot topics to be covered during the EuroPCR Forum sessions are the challenging implementation of the best standard of care for STEMI patients throughout Europe (with the timely use of stents), the introduction of transcatheter aortic valve implantation (TAVI) in clinical practice and the challenges related to bifurcation treatment options.
The cardiovascular community gathers in Paris May 25th-28th for EuroPCR. EuroPCR is the leading course in interventional cardiology. It is also the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). More than 12,000 participants will learn about the latest developments in the field and engage in discussions and constructive debate about the best…
Cancer Research UK has joined forces with the British Heart Foundation (BHF) and Diabetes UK to launch a new campaign to raise awareness of the dangers of carrying excess weight around the waist. A survey to launch the 'Active Fat' campaign found that 71 per cent of respondents admitted to carrying excess weight around their middle.
New drugs that are helping fight a multi-front war on cancer may do the same for cardiovascular disease, Medical College of Georgia researchers said. Cancer and cardiovascular disease, both among top U.S. killers, share inflammation as a cause. Heat shock protein 90 inhibitors as a treatment could become additional common ground, said Dr. John Catravas, director of MCG's Vascular Biology Center.
Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject. Studying Drosophila…